Seoul National University Hospital chooses RayCare : RaySearch Laboratories

STOCKHOLM , July 1, 2022 /PRNewswire/ — RaySearch Laboratories AB (publ) announces that Seoul National University Hospital (SNUH) in South Korea placed an order for the RayCare®* oncology information system. Recently, the hospital invested in the RaySearch RayStation®* treatment planning system.

In April 2022 the SNUH Carbon Ion Center has ordered the RayStation treatment planning system, for use with its Toshiba heavy ion therapy system. The hospital has now decided to invest in RayCare as an oncology information system.

Carbon ion therapy is a very advanced radiation therapy technique that can be effective for complex tumors that are difficult to treat with conventional methods. SNUH is the second carbon ion center in Korea to select RaySearch with RayStation and RayCare, the first customer was Yonsei Cancer Center in Seoul.

Teacher Hong-Gyun WuDirector of SNUH Gijang Cancer Center for Heavy Ion Therapy and Study, SNUH, says, “With the introduction of RaySearch software (RayStation, RayCare), SNUH has taken a step further to open a cancer center for heavy ion therapy and study. the study of heavy ions. SNUH will take the initiative to contribute to society by stimulating research and development as well as the treatment of cancer patients.”

Johan Löf, Founder and CEO of RaySearch, says: “Recently SNUH decided to invest in our RayStation treatment planning system. I am now happy to announce that this leading hospital has also decided to purchase RayCare for its carbon ion center. With the additional order from SNUH RaySearch confirms our market leadership position in this unique segment and recognizes the fact that the number of new customers choosing RayCare as their oncology information system is increasing.”

For more information please contact:
Johan Löf, Founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]

Björn Hårdemark, Acting Chief Financial Officer, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 709 564 217
[email protected]

This information was brought to you by Cision,c3593330

The following files are available for download:

SOURCE RaySearch Laboratories

Comments are closed.